Loading…

McBride plcMCB.LCompetitor analysis, valuation and peers

United Kingdom · GBP·Consumer Staples›Household/Personal Care
Momentum neutral 58
Mkt cap
$377M
US dollars, full cap
Free float
81%
of shares outstanding
$/day
$528,993
20-day average traded
Fwd P/E
8.4×
forward earnings
ROIC−WACC
+8.3 pp
WACC 10.2%
Hurdle
-7 pp
Req g minus delivered
Next earnings
97 days
23 Feb 2027
Close · GBP£175.80
1D-0.7%
1W-2.8%
1M-4.1%
3M+6.9%
6M+7.5%
YTD+19.9%
1Y+61.6%
ATR %3.3%
52w lowhigh17.9% off high

What McBride does

Employees: 3,236

McBride at a glance

Size McBride (MCB.L) is a United Kingdom Consumer Staples company (Household/Personal Care) with a market value of $377M, the 325th largest of 355 United Kingdom companies the cockpit tracks. Shares closed at £175.80 on 18 Nov 2026.

Performance Over six months the shares gained 7.5%, against -16.6% for the median peer and +0.1% for the United Kingdom market (cap-weighted) — 7th highest of 21 in its peer set.

Growth Revenue grew 0.8% over the last twelve months (peer median +8.9%); the operating margin is 6.2% (peer median 8.2%).

Valuation It trades at 8.4× forward earnings against a peer median of 20.1× (cheapest of 17).

Price implies For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is -7 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 8.3 points above its cost of capital (10.2% WACC).

Next results Next results expected around 23 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026MCB.L 110Peer median 85
Six months, rebased to 100: McBride against the median of its 20 peers (local-currency closes).

McBride financials

Reported figures in GBP; fiscal year ends 2026-06-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
Revenue£934M£934M£926M£935M£889M
Revenue growth—+1%-1%+5%—
Gross profit£343M£343M£340M£346M£261M
EBITDA£80.1M£80.4M£85.1M£92.2M£34.0M
Net income£30.0M£30.0M£33.2M£33.3M-£11.5M
Free cash flow£13.4M£13.4M£43.1M£44.9M£800,000
Capital expenditure£31.2M£31.2M£30.4M£19.6M£12.0M
Total debtn/a£188M£139M£141M£168M

Quarterly statements and history in the cockpit →

McBride competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%-20%-10%0%+10%600249001230603630001206301009600735PZCBAJAJCON4919JYOTHYLAB300740GALAXYSURF241710DM00013286031933011084928MCB.L6-month return →1-month return →
Up and to the right = strong over both horizons. McBride is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%50×100×001230603630001206301009PZCBAJAJCON6050094919JYOTHYLAB300740GALAXYSURF2417106031933011084928MCB.LRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. McBride is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%-20%0%20%001206600735PZCBAJAJCON6050094919JYOTHYLAB300740GALAXYSURFDM00013286031933011084928MCB.LGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. McBride is the large dot.

McBride competitors and peer comparison

How McBride compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

McBride against its 20 peers (data as of 18 Nov 2026)
MeasureMCB.LPeer medianRank in peer set
1-month return-4.1%-9.5%8th highest of 21
6-month return+7.5%-16.6%7th highest of 21
Distance from 52-week high-17.9%-38.0%5th highest of 21
Revenue growth (TTM)+0.8%+8.9%5th lowest of 21
Operating margin6.2%8.2%10th lowest of 21
Forward P/E8.4×20.1×cheapest of 17
Growth the price implies (Req g, 7 yrs)-0.7%2.8%6th least demanding of 15
Growth delivered (Del g)+6.5%+6.2%7th highest of 15
Hurdle (Req g minus delivered)-7.2 pp-3.9 pp6th least demanding of 15
ROIC minus cost of capital+8.3 pp+1.4 pp6th highest of 21
EV / EBITDA5.1×10.7×2nd cheapest of 9
Net debt / EBITDA1.5×-1.2×most indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
McBride MCB.LUnited Kingdom$377M+7%+1%6%8.4×-0.7%+6.5%
Liuzhou Liangmianzhen 600249.SSChina$379M-19%-11%-7%n/an/an/a
Jinglv Environment Science & Technology 001230.SZChina$392M-25%+28%11%13.9×n/an/a
Lafang China 603630.SSChina$414M-19%+5%3%37.6×n/an/a
Tianjin Yiyi Hygiene Products 001206.SZChina$429M-15%-8%9%19.9×1.9%+6.3%
Hangzhou Coco Healthcare Products 301009.SZChina$316M-26%+10%0%110.7×n/an/a
Qingdao Kingking Applied Chemistry 002094.SZChina$454M-26%+3%4%n/an/an/a
Shandong Hiking International 600735.SSChina$309M-28%-11%-2%n/a-7.5%+1.5%
PZ Cussons PZC.LUnited Kingdom$527M+13%+5%11%12.7×-2.3%-2.1%
Bajaj Consumer Care BAJAJCON.NSIndia$560M-24%+29%22%19.7×14.8%+5.0%
Hangzhou Haoyue Personal Care 605009.SSChina$726M-18%+10%6%17.7×4.4%+7.7%
Milbon 4919.TJapan$743M+48%+8%14%25.7×-3.3%+8.2%
Jyothy Labs JYOTHYLAB.NSIndia$762M-9%+5%8%40.8×34.5%+8.9%
SYoung 300740.SZChina$816M-48%+14%3%33.4×14.0%+6.1%
Galaxy Surfactants GALAXYSURF.NSIndia$845M+22%+30%9%17.6×18.5%+13.7%
Cosmecca Korea 241710.KSSouth Korea$847M+23%+42%12%16.3×n/an/a
PSC DM0.SISingapore$163M-14%+2%6%n/a-16.3%+0.2%
Dencare (Chongqing) Oral Care 001328.SZChina$912M+13%+10%11%27.9×3.7%+10.8%
Runben Biotechnology 603193.SSChina$918M-30%+13%21%18.5×1.5%+28.4%
Tongling Jieya Biologic Technology 301108.SZChina$933M+56%+24%5%52.5×28.5%+0.8%
Noevir 4928.TJapan$978M+7%-3%28%20.4×-12.8%+4.1%

Questions

Which companies are McBride's closest peers?
The cockpit's peer set: Liuzhou Liangmianzhen (600249.SS), Jinglv Environment Science & Technology (001230.SZ), Lafang China (603630.SS), Tianjin Yiyi Hygiene Products (001206.SZ), Hangzhou Coco Healthcare Products (301009.SZ), Qingdao Kingking Applied Chemistry (002094.SZ), Shandong Hiking International (600735.SS), PZ Cussons (PZC.L).
Is McBride expensive compared with its peers?
On forward p/e it trades at 8.4× against a peer median of 20.1×, cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is -7 pp: the price already allows for a slowdown.
How has McBride stock performed?
Over six months to 18 Nov 2026 the shares returned +7.5% against -16.6% for the median peer; over one year +61.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.